0.017665 0.000000 0.000000 0.000000 0.016434 0.000000 0.000000 0.000000 0.029533 0.00000 0.00000 0.00000 Matsushima, M. Inaka, K. Yamada, T. Sekiguchi, K. Kikuchi, M. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 4 90.00 90.00 90.00 56.610 60.850 33.860 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking Cl -1 35.453 CHLORIDE ION non-polymer C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Biol.Chem. JBCHA3 0071 0021-9258 268 10588 10592 8486712 Structural and functional analyses of the Arg-Gly-Asp sequence introduced into human lysozyme. 1993 US Science SCIEAS 0038 0036-8075 258 987 Structure of a Fibronectin Type III Domain from Tenascin Phased by MAD Analysis of the Selenomethionyl Protein 1992 US J.Biol.Chem. JBCHA3 0071 0021-9258 266 12599 The Crystal Structure of a Mutant Human Lysozyme C77(Slash)95A with Increased Secretion Efficiency in Yeast 1991 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 x-ray 1 1.0 15137.105 HUMAN LYSOZYME 3.2.1.17 1 man polymer 35.453 CHLORIDE ION 2 syn non-polymer 18.015 water 82 nat water no no KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKTPGAVRGDSNA CHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKTPGAVRGDSNA CHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo sample 9606 Homo sapiens 1.93 36.14 pdbx_database_status struct_conf struct_conf_type repository Initial release Version format compliance Version format compliance Derived calculations Other 1 0 1993-10-31 1 1 2008-03-24 1 2 2011-07-13 1 3 2017-11-29 _pdbx_database_status.process_site Y BNL 1993-02-03 REL REL CL CHLORIDE ION HOH water CL 131 2 CL CL 131 A CL 132 2 CL CL 132 A HOH 135 3 HOH HOH 135 A HOH 136 3 HOH HOH 136 A HOH 137 3 HOH HOH 137 A HOH 138 3 HOH HOH 138 A HOH 139 3 HOH HOH 139 A HOH 140 3 HOH HOH 140 A HOH 141 3 HOH HOH 141 A HOH 142 3 HOH HOH 142 A HOH 143 3 HOH HOH 143 A HOH 144 3 HOH HOH 144 A HOH 145 3 HOH HOH 145 A HOH 146 3 HOH HOH 146 A HOH 147 3 HOH HOH 147 A HOH 149 3 HOH HOH 149 A HOH 150 3 HOH HOH 150 A HOH 151 3 HOH HOH 151 A HOH 154 3 HOH HOH 154 A HOH 156 3 HOH HOH 156 A HOH 157 3 HOH HOH 157 A HOH 158 3 HOH HOH 158 A HOH 159 3 HOH HOH 159 A HOH 160 3 HOH HOH 160 A HOH 161 3 HOH HOH 161 A HOH 162 3 HOH HOH 162 A HOH 163 3 HOH HOH 163 A HOH 165 3 HOH HOH 165 A HOH 166 3 HOH HOH 166 A HOH 167 3 HOH HOH 167 A HOH 168 3 HOH HOH 168 A HOH 171 3 HOH HOH 171 A HOH 172 3 HOH HOH 172 A HOH 173 3 HOH HOH 173 A HOH 174 3 HOH HOH 174 A HOH 175 3 HOH HOH 175 A HOH 176 3 HOH HOH 176 A HOH 177 3 HOH HOH 177 A HOH 178 3 HOH HOH 178 A HOH 179 3 HOH HOH 179 A HOH 181 3 HOH HOH 181 A HOH 183 3 HOH HOH 183 A HOH 184 3 HOH HOH 184 A HOH 185 3 HOH HOH 185 A HOH 186 3 HOH HOH 186 A HOH 187 3 HOH HOH 187 A HOH 188 3 HOH HOH 188 A HOH 189 3 HOH HOH 189 A HOH 190 3 HOH HOH 190 A HOH 191 3 HOH HOH 191 A HOH 192 3 HOH HOH 192 A HOH 193 3 HOH HOH 193 A HOH 194 3 HOH HOH 194 A HOH 195 3 HOH HOH 195 A HOH 197 3 HOH HOH 197 A HOH 198 3 HOH HOH 198 A HOH 199 3 HOH HOH 199 A HOH 200 3 HOH HOH 200 A HOH 201 3 HOH HOH 201 A HOH 202 3 HOH HOH 202 A HOH 203 3 HOH HOH 203 A HOH 204 3 HOH HOH 204 A HOH 207 3 HOH HOH 207 A HOH 208 3 HOH HOH 208 A HOH 209 3 HOH HOH 209 A HOH 210 3 HOH HOH 210 A HOH 211 3 HOH HOH 211 A HOH 212 3 HOH HOH 212 A HOH 213 3 HOH HOH 213 A HOH 215 3 HOH HOH 215 A HOH 216 3 HOH HOH 216 A HOH 217 3 HOH HOH 217 A HOH 218 3 HOH HOH 218 A HOH 220 3 HOH HOH 220 A HOH 221 3 HOH HOH 221 A HOH 222 3 HOH HOH 222 A HOH 225 3 HOH HOH 225 A HOH 227 3 HOH HOH 227 A HOH 228 3 HOH HOH 228 A HOH 231 3 HOH HOH 231 A HOH 232 3 HOH HOH 232 A HOH 233 3 HOH HOH 233 A HOH 239 3 HOH HOH 239 A HOH 241 3 HOH HOH 241 A LYS 1 n 1 LYS 1 A VAL 2 n 2 VAL 2 A PHE 3 n 3 PHE 3 A GLU 4 n 4 GLU 4 A ARG 5 n 5 ARG 5 A CYS 6 n 6 CYS 6 A GLU 7 n 7 GLU 7 A LEU 8 n 8 LEU 8 A ALA 9 n 9 ALA 9 A ARG 10 n 10 ARG 10 A THR 11 n 11 THR 11 A LEU 12 n 12 LEU 12 A LYS 13 n 13 LYS 13 A ARG 14 n 14 ARG 14 A LEU 15 n 15 LEU 15 A GLY 16 n 16 GLY 16 A MET 17 n 17 MET 17 A ASP 18 n 18 ASP 18 A GLY 19 n 19 GLY 19 A TYR 20 n 20 TYR 20 A ARG 21 n 21 ARG 21 A GLY 22 n 22 GLY 22 A ILE 23 n 23 ILE 23 A SER 24 n 24 SER 24 A LEU 25 n 25 LEU 25 A ALA 26 n 26 ALA 26 A ASN 27 n 27 ASN 27 A TRP 28 n 28 TRP 28 A MET 29 n 29 MET 29 A CYS 30 n 30 CYS 30 A LEU 31 n 31 LEU 31 A ALA 32 n 32 ALA 32 A LYS 33 n 33 LYS 33 A TRP 34 n 34 TRP 34 A GLU 35 n 35 GLU 35 A SER 36 n 36 SER 36 A GLY 37 n 37 GLY 37 A TYR 38 n 38 TYR 38 A ASN 39 n 39 ASN 39 A THR 40 n 40 THR 40 A ARG 41 n 41 ARG 41 A ALA 42 n 42 ALA 42 A THR 43 n 43 THR 43 A ASN 44 n 44 ASN 44 A TYR 45 n 45 TYR 45 A ASN 46 n 46 ASN 46 A ALA 47 n 47 ALA 47 A GLY 48 n 48 GLY 48 A ASP 49 n 49 ASP 49 A ARG 50 n 50 ARG 50 A SER 51 n 51 SER 51 A THR 52 n 52 THR 52 A ASP 53 n 53 ASP 53 A TYR 54 n 54 TYR 54 A GLY 55 n 55 GLY 55 A ILE 56 n 56 ILE 56 A PHE 57 n 57 PHE 57 A GLN 58 n 58 GLN 58 A ILE 59 n 59 ILE 59 A ASN 60 n 60 ASN 60 A SER 61 n 61 SER 61 A ARG 62 n 62 ARG 62 A TYR 63 n 63 TYR 63 A TRP 64 n 64 TRP 64 A CYS 65 n 65 CYS 65 A ASN 66 n 66 ASN 66 A ASP 67 n 67 ASP 67 A GLY 68 n 68 GLY 68 A LYS 69 n 69 LYS 69 A THR 70 n 70 THR 70 A PRO 71 n 71 PRO 71 A GLY 72 n 72 GLY 72 A ALA 73 n 73 ALA 73 A VAL 74 n 74 VAL 74 A ARG 74 n 75 A ARG 74 A GLY 74 n 76 B GLY 74 A ASP 74 n 77 C ASP 74 A SER 74 n 78 D SER 74 A ASN 75 n 79 ASN 75 A ALA 76 n 80 ALA 76 A CYS 77 n 81 CYS 77 A HIS 78 n 82 HIS 78 A LEU 79 n 83 LEU 79 A SER 80 n 84 SER 80 A CYS 81 n 85 CYS 81 A SER 82 n 86 SER 82 A ALA 83 n 87 ALA 83 A LEU 84 n 88 LEU 84 A LEU 85 n 89 LEU 85 A GLN 86 n 90 GLN 86 A ASP 87 n 91 ASP 87 A ASN 88 n 92 ASN 88 A ILE 89 n 93 ILE 89 A ALA 90 n 94 ALA 90 A ASP 91 n 95 ASP 91 A ALA 92 n 96 ALA 92 A VAL 93 n 97 VAL 93 A ALA 94 n 98 ALA 94 A CYS 95 n 99 CYS 95 A ALA 96 n 100 ALA 96 A LYS 97 n 101 LYS 97 A ARG 98 n 102 ARG 98 A VAL 99 n 103 VAL 99 A VAL 100 n 104 VAL 100 A ARG 101 n 105 ARG 101 A ASP 102 n 106 ASP 102 A PRO 103 n 107 PRO 103 A GLN 104 n 108 GLN 104 A GLY 105 n 109 GLY 105 A ILE 106 n 110 ILE 106 A ARG 107 n 111 ARG 107 A ALA 108 n 112 ALA 108 A TRP 109 n 113 TRP 109 A VAL 110 n 114 VAL 110 A ALA 111 n 115 ALA 111 A TRP 112 n 116 TRP 112 A ARG 113 n 117 ARG 113 A ASN 114 n 118 ASN 114 A ARG 115 n 119 ARG 115 A CYS 116 n 120 CYS 116 A GLN 117 n 121 GLN 117 A ASN 118 n 122 ASN 118 A ARG 119 n 123 ARG 119 A ASP 120 n 124 ASP 120 A VAL 121 n 125 VAL 121 A ARG 122 n 126 ARG 122 A GLN 123 n 127 GLN 123 A TYR 124 n 128 TYR 124 A VAL 125 n 129 VAL 125 A GLN 126 n 130 GLN 126 A GLY 127 n 131 GLY 127 A CYS 128 n 132 CYS 128 A GLY 129 n 133 GLY 129 A VAL 130 n 134 VAL 130 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O LYS 1 A O LYS 1 A N THR 40 A N THR 40 A O ALA 42 A O ALA 42 A N GLY 55 A N GLY 55 A O THR 52 A O THR 52 A N SER 61 A N SER 61 1 A ARG 119 0.072 SIDE CHAIN 1 23.92 2.20 113.40 137.32 A A A CA CB CG GLU GLU GLU 4 4 4 N 1 -13.63 2.00 118.30 104.67 A A A CG CD OE2 GLU GLU GLU 7 7 7 N 1 -4.03 0.50 120.30 116.27 A A A NE CZ NH1 ARG ARG ARG 10 10 10 N 1 4.15 0.50 120.30 124.45 A A A NE CZ NH2 ARG ARG ARG 10 10 10 N 1 -5.53 0.50 120.30 114.77 A A A NE CZ NH2 ARG ARG ARG 14 14 14 N 1 7.36 0.90 118.30 125.66 A A A CB CG OD1 ASP ASP ASP 18 18 18 N 1 10.50 1.40 123.60 134.10 A A A CD NE CZ ARG ARG ARG 41 41 41 N 1 8.09 0.90 118.30 126.39 A A A CB CG OD1 ASP ASP ASP 49 49 49 N 1 9.57 1.40 123.60 133.17 A A A CD NE CZ ARG ARG ARG 50 50 50 N 1 6.43 0.50 120.30 126.73 A A A NE CZ NH1 ARG ARG ARG 50 50 50 N 1 -3.04 0.50 120.30 117.26 A A A NE CZ NH2 ARG ARG ARG 50 50 50 N 1 10.13 1.50 110.10 120.23 A A A CB CA C ALA ALA ALA 73 73 73 N A B B 1 15.34 2.10 122.30 137.64 A A A C N CA ARG GLY GLY 74 74 74 Y 1 10.13 0.90 118.30 128.43 A A A CB CG OD1 ASP ASP ASP 87 87 87 N 1 -8.05 0.90 118.30 110.25 A A A CB CG OD2 ASP ASP ASP 87 87 87 N 1 5.29 0.50 120.30 125.59 A A A NE CZ NH1 ARG ARG ARG 98 98 98 N 1 9.32 1.40 123.60 132.92 A A A CD NE CZ ARG ARG ARG 101 101 101 N 1 4.41 0.50 120.30 124.71 A A A NE CZ NH1 ARG ARG ARG 101 101 101 N 1 -5.41 0.90 118.30 112.89 A A A CB CG OD2 ASP ASP ASP 102 102 102 N 1 4.92 0.50 120.30 125.22 A A A NE CZ NH1 ARG ARG ARG 113 113 113 N 1 -4.36 0.50 120.30 115.94 A A A NE CZ NH2 ARG ARG ARG 113 113 113 N 1 -4.30 0.50 120.30 116.00 A A A NE CZ NH2 ARG ARG ARG 115 115 115 N 1 -7.10 0.90 118.30 111.20 A A A CB CG OD2 ASP ASP ASP 120 120 120 N 1 A A O O HOH HOH 166 222 2.08 1_555 2_554 1 A VAL 74 19.41 -99.62 1 A ASN 75 -141.18 55.31 0.146 1.8 5.0 10744 1 1.8 5.0 82 1142 2 0 1058 0.015 0.015 0.039 0.039 refinement PROLSQ LYSOZYME (E.C.3.2.1.17) MUTANT WITH FOUR AMINO ACID RESIDUES (ARG 74A, GLY 74B, ASP 74C AND SER 74D) INSERTED BETWEEN VAL 74 AND ASN 75 STRUCTURAL AND FUNCTIONAL ANALYSES OF THE ARG-GLY-ASP SEQUENCE INTRODUCED INTO HUMAN LYSOZYME 1 N N 2 N N 2 N N 3 N N A ARG 5 A ARG 5 HELX_P A ARG 14 A ARG 14 1 A 10 A LEU 25 A LEU 25 HELX_P A GLU 35 A GLU 35 1 B 11 A SER 80 A SER 84 HELX_P A LEU 85 A LEU 89 5 E 6 A ALA 90 A ALA 94 HELX_P A VAL 99 A VAL 103 1 C 10 A VAL 110 A VAL 114 HELX_P A CYS 116 A CYS 120 1 D 7 disulf 2.031 A CYS 6 A SG CYS 6 1_555 A CYS 128 A SG CYS 132 1_555 disulf 2.072 A CYS 30 A SG CYS 30 1_555 A CYS 116 A SG CYS 120 1_555 disulf 2.037 A CYS 65 A SG CYS 65 1_555 A CYS 81 A SG CYS 85 1_555 disulf 2.032 A CYS 77 A SG CYS 81 1_555 A CYS 95 A SG CYS 99 1_555 HYDROLASE(O-GLYCOSYL) HYDROLASE(O-GLYCOSYL) LYSC_HUMAN UNP 1 1 P61626 MKALIVLGLVLLSVTVQGKVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSR YWCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV 19 144 1LZ5 1 126 P61626 A 1 1 130 1 INSERTION ARG 74 1LZ5 A A P61626 UNP 75 1 INSERTION GLY 74 1LZ5 B A P61626 UNP 76 1 INSERTION ASP 74 1LZ5 C A P61626 UNP 77 1 INSERTION SER 74 1LZ5 D A P61626 UNP 78 2 3 anti-parallel anti-parallel anti-parallel A LYS 1 A LYS 1 A PHE 3 A PHE 3 A TYR 38 A TYR 38 A THR 40 A THR 40 A ALA 42 A ALA 42 A ASN 46 A ASN 46 A SER 51 A SER 51 A GLY 55 A GLY 55 A ILE 59 A ILE 59 A SER 61 A SER 61 BINDING SITE FOR RESIDUE CL A 131 Software 4 BINDING SITE FOR RESIDUE CL A 132 Software 3 A SER 80 A SER 84 4 1_555 A ARG 107 A ARG 111 4 4_457 A HOH 232 D HOH 4 1_555 A HOH 241 D HOH 4 1_555 A ASN 27 A ASN 27 3 4_457 A ASN 66 A ASN 66 3 1_555 A SER 80 A SER 84 3 1_555 19 P 21 21 21